Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester

Objective. To determine plasma markers of oxidative stress during the second and third trimester of pregnancy in patients with gestational diabetes mellitus (GDM). Study Design. We conducted a prospective nested case-control study involving 400 pregnant women, 22 of whom developed GDM. As control gr...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongwei Li, Qian Yin, Ning Li, Zhenbo Ouyang, Mei Zhong
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Obstetrics and Gynecology International
Online Access:http://dx.doi.org/10.1155/2016/3865454
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566982956810240
author Hongwei Li
Qian Yin
Ning Li
Zhenbo Ouyang
Mei Zhong
author_facet Hongwei Li
Qian Yin
Ning Li
Zhenbo Ouyang
Mei Zhong
author_sort Hongwei Li
collection DOAJ
description Objective. To determine plasma markers of oxidative stress during the second and third trimester of pregnancy in patients with gestational diabetes mellitus (GDM). Study Design. We conducted a prospective nested case-control study involving 400 pregnant women, 22 of whom developed GDM. As control group, 30 normal pregnant women were chosen randomly. Plasma samples were analyzed for 8-iso-prostaglandin F2α (8-iso-PGF2α), advanced oxidative protein products (AOPPs), protein carbonyl (PCO), glutathione peroxidase-3 (GPX-3), and paraoxonase-1 (PON1) at 16–20 weeks, 24–28 weeks, and 32–36 weeks of gestation. Results. Compared to control subjects, the plasma levels of PCO, AOPPs, and 8-iso-PGF2α were elevated at 16–20 weeks’ and 32–36 weeks’ gestation in GDM. There was no significant difference in PCO and 8-iso-PGF2α at 24–28 weeks in GDM. GPX-3 was statistically significantly increased at 16–20 weeks and 32–36 weeks in GDM. PON1 reduced in patients with GDM. No significant differences were found at 24–28 and 32–36 weeks between the GDM and control groups. In GDM, PCO, AOPPs, and 8-iso-PGF2α levels were higher and GPX-3 and PON1 levels were lower in the second than the third trimester. Conclusion. Oxidation status increased in GDM, especially protein oxidation, which may contribute to the pathogenesis of GDM.
format Article
id doaj-art-afaeac6e3d5646e2b43e7a3e7f59d1f1
institution Kabale University
issn 1687-9589
1687-9597
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Obstetrics and Gynecology International
spelling doaj-art-afaeac6e3d5646e2b43e7a3e7f59d1f12025-02-03T01:02:40ZengWileyObstetrics and Gynecology International1687-95891687-95972016-01-01201610.1155/2016/38654543865454Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third TrimesterHongwei Li0Qian Yin1Ning Li2Zhenbo Ouyang3Mei Zhong4Department of Obstetrics & Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Obstetrics & Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Obstetrics & Gynecology, Puyang Oilfield General Hospital, Puyang, ChinaDepartment of Gynecology, Guangdong No. 2 Provincial People’s Hospital, Guangzhou, ChinaDepartment of Obstetrics & Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaObjective. To determine plasma markers of oxidative stress during the second and third trimester of pregnancy in patients with gestational diabetes mellitus (GDM). Study Design. We conducted a prospective nested case-control study involving 400 pregnant women, 22 of whom developed GDM. As control group, 30 normal pregnant women were chosen randomly. Plasma samples were analyzed for 8-iso-prostaglandin F2α (8-iso-PGF2α), advanced oxidative protein products (AOPPs), protein carbonyl (PCO), glutathione peroxidase-3 (GPX-3), and paraoxonase-1 (PON1) at 16–20 weeks, 24–28 weeks, and 32–36 weeks of gestation. Results. Compared to control subjects, the plasma levels of PCO, AOPPs, and 8-iso-PGF2α were elevated at 16–20 weeks’ and 32–36 weeks’ gestation in GDM. There was no significant difference in PCO and 8-iso-PGF2α at 24–28 weeks in GDM. GPX-3 was statistically significantly increased at 16–20 weeks and 32–36 weeks in GDM. PON1 reduced in patients with GDM. No significant differences were found at 24–28 and 32–36 weeks between the GDM and control groups. In GDM, PCO, AOPPs, and 8-iso-PGF2α levels were higher and GPX-3 and PON1 levels were lower in the second than the third trimester. Conclusion. Oxidation status increased in GDM, especially protein oxidation, which may contribute to the pathogenesis of GDM.http://dx.doi.org/10.1155/2016/3865454
spellingShingle Hongwei Li
Qian Yin
Ning Li
Zhenbo Ouyang
Mei Zhong
Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester
Obstetrics and Gynecology International
title Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester
title_full Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester
title_fullStr Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester
title_full_unstemmed Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester
title_short Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester
title_sort plasma markers of oxidative stress in patients with gestational diabetes mellitus in the second and third trimester
url http://dx.doi.org/10.1155/2016/3865454
work_keys_str_mv AT hongweili plasmamarkersofoxidativestressinpatientswithgestationaldiabetesmellitusinthesecondandthirdtrimester
AT qianyin plasmamarkersofoxidativestressinpatientswithgestationaldiabetesmellitusinthesecondandthirdtrimester
AT ningli plasmamarkersofoxidativestressinpatientswithgestationaldiabetesmellitusinthesecondandthirdtrimester
AT zhenboouyang plasmamarkersofoxidativestressinpatientswithgestationaldiabetesmellitusinthesecondandthirdtrimester
AT meizhong plasmamarkersofoxidativestressinpatientswithgestationaldiabetesmellitusinthesecondandthirdtrimester